Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam

Biochemical Society Transactions

Volumn 41, Issue 5, 2013, Pages 1331-1334

  Stockburger, Carola ^a   Kurz, Christopher ^a   Koch, Konrad A ^a   Eckert, Schamim H ^a   Leuner, Kristina ^b   Müller, Walter E ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aging; Alzheimer's disease; Mitochondrial morphology; Piracetam

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID PRECURSOR PROTEIN; CYTOCHROME C OXIDASE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MITOCHONDRIAL DNA; PIRACETAM; REACTIVE OXYGEN METABOLITE; ROTENONE; SUPEROXIDE DISMUTASE;

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CELL STRAIN HEK293; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; DRUG BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FOLDING; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; METABOLIC PHENOMENA; MITOCHONDRIA; PIRACETAM; REACTIVE OXYGEN SPECIES;

EID: 84884605867     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130054     Document Type: Article

References (25)

1. Benard, G. and Rossignol, R. (2008) Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid. Redox Signaling 10, 1313-1342
2. Picard, M., Shirihai, O.S., Gentil, B.J. and Burelle, Y. (2013) Mitochondrial morphology transitions and functions: implications for retrograde signaling? Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R393-R406
3. Mattson, M.P. and Magnus, T. (2006) Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7, 278-294
4. Reddy, P.H. and Beal, M.F. (2008) Amyloid β, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 14, 45-53
5. Hauptmann, S., Scherping, I., Drose, S., Brandt, U., Schulz, K.L., Jendrach, M., Leuner, K., Eckert, A. and Muller, W.E. (2009) Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol. Aging 30, 1574-1586
6. Leuner, K., Schütt, T., Kurz, C., Eckert, S.H., Schiller, C., Occhipinti, A., Mai, S., Jendrach, M., Eckert, G.P., Kruse, S.E. et al. (2012) Mitochondrion-derived deactive oxygen species lead to enhanced amyloid β formation. Antioxid. Redox Signaling 16, 1421-1433
7. Mattson, M.P., Gleichmann, M. and Cheng, A. (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60, 748-766
8. M̈uller, W.E., Eckert, A., Kurz, C., Eckert, G.P. and Leuner, K. (2010) Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease - therapeutic aspects. Mol. Neurobiol. 41, 159-171
9. Reddy, P.H. (2009) Amyloid β, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp. Neurol. 218, 286-292
10. Knott, A.B. and Bossy-Wetzel, E. (2008) Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration. Ann. N.Y. Acad. Sci. 1147, 283-292
11. Wang, X., Su, B., Lee, H., Li, X., Perry, G., Smith, M.A. and Zhu, X. (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 29, 9090-9103
12. Su, B., Wang, X., Bonda, D., Perry, G., Smith, M. and Zhu, X. (2010) Abnormal mitochondrial dynamics: a novel therapeutic target for Alzheimer's disease. Mol. Neurobiol. 41, 87-96
13. Eckert, S.H., Eckmann, J., Renner, K., Eckert, G.P., Leuner, K. and Muller, W.E. (2012) Dimebon ameliorates amyloid-β induced impairments of mitochondrial form and function. J. Alzheimer's Dis. 31, 21-32
14. Giurgea, C.E. (1982) The nootropic concept and its prospective implications. Drug Dev. Res. 2, 441-446
15. Leuner, K., Kurz, C., Guidetti, G., Orgogozo, J.M. and Müller, W.E. (2010) Improved mitochondrial function in brain aging and Alzheimer disease: the new mechanism of action of the old metabolic enhancer piracetam. Front. Neurosci. 4, 44
16. Leuner, K., Hauptmann, S., Abdel-Kader, R., Scherping, I., Keil, U., Strosznajder, J.B., Eckert, A. and Muller, W.E. (2007) Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid. Redox Signaling 9, 1659-1675
17. Müller, W.E., Eckert, G.P. and Eckert, A. (1999) Piracetam: novelty in a unique mode of action. Pharmacopsychiatry 32 (Suppl.), 2-9
18. Keil, U., Scherping, I., Hauptmann, S., Schuessel, K., Eckert, A. and Müller, W.E. (2006) Piracetam improves mitochondrial dysfunction following oxidative stress. Br. J. Pharmacol. 147, 199-208
19. Kurz, C., Ungerer, I., Lipka, U., Kirr, S., Schütt, T., Eckert, A., Leuner, K. and Müller, W.E. (2010) The metabolic enhancer piracetam ameliorates β-amyloid peptide induced impairment of mitochondrial function and neuritic outgrowth. Br. J. Pharmacol. 160, 246-257
20. Schiller, C., Leuner, K. and Müller, W.E. (2012) Mitochondrial dysfunction in a human neuronal cell model of early Alzheimer's disease. Neuroscience 2012 Meeting, New Orleans, LA, U.S.A., 13-17 October 2012, Abstract 850.16
21. Müller, W.E., Koch, S., Scheuer, K., Rostock, A. and Bartsch, R. (1997) Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. Biochem. Pharmacol. 53, 135-140
22. Burchell, V.S., Gandhi, S., Deas, E., Wood, N.W., Abramov, A.Y. and Plun-Favreau, H. (2010) Targeting mitochondrial dysfunction in neurodegenerative disease: part II. Expert Opin. Ther. Targets 14, 497-511
23. Benard, G., Bellance, N., James, D., Parrone, P., Fernandez, H., Letellier, T. and Rossignol, R. (2007) Mitochondrial bioenergetics and structural network organization. J. Cell Sci. 120, 838-848
24. Eckmann, J., Eckert, S.H., Leuner, K., Muller, W.E. and Eckert, G.P. (2012) Mitochondria: mitochondrial membranes in brain ageing and neurodegeneration. Int. J. Biochem. Cell Biol. 45, 76-80
25. Kurz, C. (2012) Mitochondriale Dysfunktion als Grundlage reduzierter synaptischer Plastizität bei Alzheimer-Demenz. Ph.D. Thesis, Goethe University, Frankfurt, Germany